ENP112: Osteoporosis and the SABRE Project

ENP112: Osteoporosis and the SABRE Project

Author: Endocrine Society May 18, 2026 Duration: 24:00

The U.S. Food and Drug Administration recently qualified "total hip bone mineral density" as a surrogate endpoint to support clinical trials for osteoporosis drugs. This decision will significantly impact clinical trials moving forward, as the traditional endpoint of "fracture outcomes" presented many challenges regarding sample size, duration, and cost.

The change came about because of findings from the study to advance bone mineral density as a Regulatory Endpoint Project, also known as the SABRE project.

What is the SABRE project, and how did it arrive at these findings? How will this decision affect the design of clinical trials and time to approval of new osteoporosis therapies?

To help answer these questions and many more, Host Aaron Lohr spoke with three leaders of the SABRE Project: Dennis M. Black, PhD, professor of epidemiology and biostatistics at the University of California, San Francisco; Richard Eastell, MBChB, PhD, FRCP, FMedSci, professor of bone metabolism at the University of Sheffield, and Mary L. Bouxsein, PhD, professor of orthopedic surgery at Harvard Medical School.


Ever wondered how the latest scientific discoveries actually translate to patient care or what drives the decisions of leading clinicians and researchers? The Endocrine News Podcast, produced by the Endocrine Society, sits down with those very experts to pull back the curtain on a rapidly evolving field. Each conversation goes beyond the headlines of journal articles, exploring the real-world implications of new findings in diabetes, thyroid disorders, hormone-related cancers, and countless other conditions. You’ll hear researchers explain the nuance behind their data, clinicians debate emerging treatment protocols, and thought leaders outline where the science is headed next. This isn't a dry lecture; it's a direct line to the people shaping modern endocrinology. The discussions are grounded and accessible, designed for anyone with a professional or deep personal interest in hormonal health. Whether you're a practicing physician, a trainee, a dedicated patient advocate, or simply fascinated by how the body's intricate systems work, this podcast offers substantive insights. Tuning in provides a unique way to stay current with the trends and controversies that define the specialty today. The entire archive is a free resource, reflecting the Society's mission to advance endocrine science and public understanding. Suggestions for future topics are always welcome, keeping the dialogue connected to the community's most pressing questions.
Author: Language: English Episodes: 50

Endocrine News Podcast
Podcast Episodes
ENP85: Treat and Reduce Obesity Act [not-audio_url] [/not-audio_url]

Duration: 13:25
In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Raul Ruiz, MD, a physician and currently the U.S. Representative for California’s 2…
ENP84: Fibrodysplasia Ossificans Progressiva [not-audio_url] [/not-audio_url]

Duration: 22:05
In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three guests: Eileen M. Shore, PhD, Cali and Weldon Research Professor in FOP and co-dir…
ENP82: PFAS [not-audio_url] [/not-audio_url]

Duration: 19:03
In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be f…
ENP81: Obesity Fellows Program [not-audio_url] [/not-audio_url]

Duration: 12:09
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to tr…
ENP80: Metabolic and Neuroendocrine Effects of Short Sleep [not-audio_url] [/not-audio_url]

Duration: 18:39
We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we d…
ENP79: Type 1 Diabetes Update [not-audio_url] [/not-audio_url]

Duration: 35:04
Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hir…
ENP77: Phthalates and Endocrine Puberty [not-audio_url] [/not-audio_url]

Duration: 12:01
We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnel…